JAMA Ophthalmology

Papers
(The H4-Index of JAMA Ophthalmology is 38. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-11-01 to 2024-11-01.)
ArticleCitations
Progression of Myopia in School-Aged Children After COVID-19 Home Confinement292
Performance of an Artificial Intelligence Chatbot in Ophthalmic Knowledge Assessment146
Association of Ocular Adverse Events With Inactivated COVID-19 Vaccination in Patients in Abu Dhabi106
Spectacle Lenses With Aspherical Lenslets for Myopia Control vs Single-Vision Spectacle Lenses105
Safety and Efficacy of Low-Dose Atropine Eyedrops for the Treatment of Myopia Progression in Chinese Children97
A Global Assessment of Eye Health and Quality of Life97
Characterization of Retinal Microvascular and Choroidal Structural Changes in Parkinson Disease95
Effect of Intravitreous Anti–Vascular Endothelial Growth Factor vs Sham Treatment for Prevention of Vision-Threatening Complications of Diabetic Retinopathy92
Evaluation of Intravitreal Aflibercept for the Treatment of Severe Nonproliferative Diabetic Retinopathy84
Prevalence of Age-Related Macular Degeneration in the US in 201979
Association of Age at Myopia Onset With Risk of High Myopia in Adulthood in a 12-Year Follow-up of a Chinese Cohort78
Rates of Myopia Development in Young Chinese Schoolchildren During the Outbreak of COVID-1975
Association of Metformin Use With Age-Related Macular Degeneration74
Prevalence of Visual Acuity Loss or Blindness in the US74
Safety Outcomes of Brolucizumab in Neovascular Age-Related Macular Degeneration72
Nicotinamide and Pyruvate for Neuroenhancement in Open-Angle Glaucoma69
Long-term Outcomes of Adding Lutein/Zeaxanthin and ω-3 Fatty Acids to the AREDS Supplements on Age-Related Macular Degeneration Progression66
Incidence and Progression of Myopia in Early Adulthood63
Presence of SARS-CoV-2 RNA in the Cornea of Viremic Patients With COVID-1961
Early Experience With Brolucizumab Treatment of Neovascular Age-Related Macular Degeneration60
Efficacy and Safety of a Proposed Ranibizumab Biosimilar Product vs a Reference Ranibizumab Product for Patients With Neovascular Age-Related Macular Degeneration57
Association of Daily Wear of Eyeglasses With Susceptibility to Coronavirus Disease 2019 Infection57
Continued Increase of Axial Length and Its Risk Factors in Adults With High Myopia54
SARS-CoV-2 on Ocular Surfaces in a Cohort of Patients With COVID-19 From the Lombardy Region, Italy53
Using Optical Coherence Tomography as a Surrogate of Measurements of Intracranial Pressure in Idiopathic Intracranial Hypertension50
Bilateral Acute Macular Neuroretinopathy After Vaccination Against SARS-CoV-249
Glaucoma-Related Adverse Events at 10 Years in the Infant Aphakia Treatment Study47
Utility of Pupillary Light Reflex Metrics as a Physiologic Biomarker for Adolescent Sport-Related Concussion47
Prevalence and Incidence of Dry Eye and Meibomian Gland Dysfunction in the United States46
Prevalence of Diabetic Retinopathy in the US in 202146
Minimally Invasive Glaucoma Surgical Techniques for Open-Angle Glaucoma43
Association Between Visual Impairment and Depression in Patients Attending Eye Clinics42
Patient Perceptions of SARS-CoV-2 Exposure Risk and Association With Continuity of Ophthalmic Care42
Association of Pegcetacoplan With Progression of Incomplete Retinal Pigment Epithelium and Outer Retinal Atrophy in Age-Related Macular Degeneration41
Presumed SARS-CoV-2 Viral Particles in the Human Retina of Patients With COVID-1940
Association of Smoking, Alcohol Consumption, Blood Pressure, Body Mass Index, and Glycemic Risk Factors With Age-Related Macular Degeneration39
Association of Patient Characteristics With Delivery of Ophthalmic Telemedicine During the COVID-19 Pandemic38
Coronavirus Disease 2019–Associated Ocular Neuropathy With Panuveitis38
COVID-19, COVID-19 Vaccinations, and Subsequent Abnormalities in the Retina38
0.060513973236084